What Is Diabetic Amyotrophy?

Diabetic muscular atrophy is the most common type of neuropathy caused by diabetes. Sympathetic somatosensory nerve damage is most common, especially multiple peripheral sensory nerve abnormalities in the distal limbs, followed by symmetric motor neuropathy.

Diabetic muscular atrophy

Introduction to diabetic muscular atrophy:

Diabetic muscular atrophy is the most common type of neuropathy caused by diabetes. Sympathetic somatosensory nerve damage is most common, especially multiple peripheral sensory nerve abnormalities in the distal limbs, followed by symmetric motor neuropathy.

Diabetic muscular atrophy is the main neuropathological change is nerve fiber segmental demyelination, and axonal mutation, etc., leading to impulse conduction disorders. Lesions are often extensive, generally distal and proximal, the disease gradually worsens, and sensory nerve damage is mostly symmetrical and multiple.

Proximal motor neuropathy of the lower limbs is also called "diabetic muscular atrophy." The disease often affects the proximal muscles of the lower limbs governed by the femoral, sciatic, and obturator nerves. Patients are mostly middle-aged and elderly patients with long-term poor diabetes control, more common in men.

Diseases such as diabetic muscular atrophy have a more rapid onset, accompanied by asymmetric persistent muscle pain, and muscle weakness and muscle atrophy occur shortly after onset, but the general sensory disturbance is not obvious. If the effective treatment as soon as possible has a good prognosis, it can be restored after 3 to 6 months.

Treatment of diabetic muscular atrophy

General treatment of diabetic muscular atrophy requires active control of blood sugar (including drugs and diet), and feasible physical therapy, such as muscle strengthening exercise, walking training, warm bath, massage, massage, etc. B vitamins are used, and B1, B6, and B12 are combined. The application of various analgesics is helpful for pain relief.

Traditional Chinese medicine treats diabetic muscular atrophy, which is relatively harmful to the body; it is currently in the experimental stage and has not yet been applied to the clinic. However, islet transplantation in mice with experimental diabetic muscular dystrophy can restore blood glucose to normal and prevent further development. This may be a promising treatment method that needs further study.